Non-alcoholic fatty liver disease (NAFLD) is recognized as an emerging health risk in obese
children and adolescents. NAFLD represents a wide spectrum of liver conditions, ranging …

Objective Impaired hepatic fatty acids oxidation results in lipid accumulation and redox
imbalance, promoting the development of fatty liver diseases and insulin resistance …

Ethnopharmacology relevance The farnesoid X receptor (FXR) is a therapeutic target of for
the treatment of non-alcoholic fatty liver disease (NAFLD) owing to its regulatory role in lipid …

Background. Obesity prevalence is increasing in children. It is associated with various
comorbidities including nonalcoholic fatty liver disease (NAFLD). Hsp90 isoforms were …

Summary Aquaporin-8 (AQP8), is a transmembrane channel protein that abounds in liver,
which mainly promotes water transport, modulating bile acid formation. However, its role in …

Objectives Non-alcoholic fatty liver disease (NAFLD) is a common obesity-related
comorbidity in childhood. In this study, we aimed to evaluate predictors of NAFLD by …

The aim of the study was to evaluate serum Endocan and Lumican levels as biomarkers for
pediatric Nonalcoholic Fatty Liver Disease (NAFLD) and to explore their associations with …

Results Metabolic syndrome was diagnosed in 69 children (24%) including 42 girls (61%,
p< 0.05). Mean age was higher (12.4 vs. 10.9, p< 0.05) in patients with metabolic syndrome …

Method This is an experimental study with a pre-test/post-test design. Twenty-five wistar rats
were placed in two control groups and three experimental groups by simple random …

Introduction. Excess weight has been recognized as a global health issue for many years. It
is an established risk factor for several chronic conditions, notably cardiovascular disease …